Column: Hedge Funds Bet Cautiously on Even Higher Oil Prices (Reuters) LONDON (Reuters) – Hedge funds added more bullish positions in crude and......
(read more)February 25 - Hedge Funds, Insider Trading - Comments
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings. The 13F......
(read more)December 17 - Hedge Funds, News - Comments
Steven Cohen Wins Dismissal of $8 billion Fairfax Short-selling Lawsuit (Reuters) (Reuters) – The billionaire Steven A. Cohen has won the dismissal......
(read more)April 3 - Hedge Funds, Insider Trading - Comments
Trading ‘BOON’ Pickens: Oil Tycoon’s Spinoff Fund Seeks Listing (Bloomberg) Legendary oil tycoon T. Boone Pickens has closed his hedge fund,......
(read more)February 28 - Hedge Funds, Insider Trading - Comments
Electronic Arts Inc. (NASDAQ:EA) (MarketWatch) The poor performance of Electronic Arts Inc.’s “Star Wars Battlefront 2” was in the spotlight on......
(read more)January 31 - Market Movers, News - Comments
1. U.S. Stock Market: “Stocks rose on Wall Street on Thursday, capping a wave of declines in major world equity markets triggered by uncertainty......
(read more)May 18 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
1. U.S. Stock Market: “The S&P 500 and the Nasdaq Composite hit fresh intraday records on Monday as a jump in oil prices to a two-week high......
(read more)May 15 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
1. US Stock Market: “U.S. equities traded mixed on Wednesday, with IBM sending the Dow Jones industrial average lower and Morgan Stanley leading......
(read more)April 19 - Commodities, Gold, Market Movers, News, Tech - Comments
1. US Stock Market: “Stocks fell on Thursday after the U.S. dropped “the mother of all bombs” in Afghanistan while bank stocks dropped......
(read more)April 13 - Commodities, Gold, Market Movers, News, Tech - Comments
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment......
(read more)December 7 - Hedge Funds, News - Comments
The three major index futures and crude are once again in the red on Tuesday amid Brexit fears. If Britain leaves the EU, there could be an unexpected......
(read more)June 14 - Market Movers, News, Tech - Comments
The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by......
(read more)November 25 - Hedge Funds, News - Comments
ImmunoGen Inc. (NASDAQ:IMGN), Vipshop Holdings Limited (NYSE:VIPS), Urban Outfitters Inc. (NASDAQ:URBN), and TerraForm Power Inc. (NASDAQ:TERP) ......
(read more)November 16 - Earnings Report, Market Movers, News - Comments
Is Nektar Therapeutics (NASDAQ:NKTR) a good investment? Now, according to many of your peers, hedge funds are assumed to be useless, outdated investment......
(read more)September 17 - News - Comments
To many investors, hedge funds are assumed to be bloated, outdated investment tools of a forgotten age. Although there are In excess of 8,000 hedge funds......
(read more)September 11 - News - Comments
Is Viropharma Inc (NASDAQ:VPHM) a good investment? If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era......
(read more)August 28 - News - Comments
Who’s crazy about Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)? If you were to ask many market players, hedge funds are seen as useless, outdated......
(read more)August 22 - News - Comments
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view. The number of bullish......
(read more)August 6 - News - Comments
Cancer is the target of a number of different biotech companies. Out of this lot, I consider Seattle Genetics, Inc. (NASDAQ:SGEN) to be one of the star......
(read more)August 6 - News - Comments
The cancer world has been abuzz after an exciting ASCO conference. Bristol Myers Squibb Co. (NYSE:BMY) presented really promising updates for its PD-......
(read more)June 14 - News - Comments
Nektar Therapeutics (NASDAQ:NKTR) was in 8 hedge funds’ portfolio at the end of March. NKTR has experienced a decrease in support from the world......
(read more)June 12 - News - Comments
There’s never a shortage of losers in the stock market. Let’s take a closer look at five of this past week’s biggest sinkers. Company......
(read more)June 10 - News - Comments
ImmunoGen, Inc. (NASDAQ:IMGN) investors should pay attention to a decrease in hedge fund interest recently. At the moment, there are dozens of methods......
(read more)April 19 - News - Comments
A lot has been written this week — at The Fool and elsewhere — about Sarepta Therapeutics Inc (NASDAQ:SRPT)‘ update on its meeting......
(read more)April 18 - News - Comments
Acorda Therapeutics Inc (NASDAQ:ACOR) was in 10 hedge funds’ portfolio at the end of the fourth quarter of 2012. ACOR investors should pay attention......
(read more)April 12 - News - Comments
The process of developing a drug from start to finish is incredibly arduous, usually involves around $1 billion in costs, and can take upwards of a decade......
(read more)April 12 - News - Comments
As I noted two weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing......
(read more)March 12 - News - Comments
As we’ve learned in recent years, getting an approval from the Food and Drug Administration is only half the battle. Successfully commercializing......
(read more)February 25 - News - Comments
With the SPDR S&P Biotech Index up 25% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......
(read more)February 23 - News - Comments
